SOAT1 and neoplasm: In malignant peripheral nerve sheath tumors, Ghonime and Cassady interrupted STAT signaling with the Jak inhibitor, ruxolitinib, and showed significantly increased oHSV replication and decreased tumor size in vivo [55].